LY6D and hepatocellular carcinoma: In the inflammation category, Lgals1 (Galectin-1), an important immune response modulator and biomarker for hepatocellular carcinoma (HCC) [73–75] was also markedly increased in SO-HFD but not HFD, as were Abcd2, Cd63, Ly6d and Ubd.